US 10435445
Peptide compound
granted A61KA61K38/00A61K47/60
Quick answer
US patent 10435445 (Peptide compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K38/00, A61K47/60, A61P, A61P1/08